Bogusz Trojanowicz

911 total citations
38 papers, 716 citations indexed

About

Bogusz Trojanowicz is a scholar working on Molecular Biology, Surgery and Nephrology. According to data from OpenAlex, Bogusz Trojanowicz has authored 38 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Surgery and 8 papers in Nephrology. Recurrent topics in Bogusz Trojanowicz's work include Dialysis and Renal Disease Management (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Muscle and Compartmental Disorders (4 papers). Bogusz Trojanowicz is often cited by papers focused on Dialysis and Renal Disease Management (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Muscle and Compartmental Disorders (4 papers). Bogusz Trojanowicz collaborates with scholars based in Germany, China and Canada. Bogusz Trojanowicz's co-authors include Cuong Hoang‐Vu, Christof Ulrich, Matthias Girndt, Henning Dralle, Roman Fiedler, Carsten Sekulla, Eric Seibert, Rainer Finke, Li Chen and Daren Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Bogusz Trojanowicz

36 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bogusz Trojanowicz Germany 17 304 161 150 100 81 38 716
Daniel Guldager Kring Rasmussen Denmark 15 148 0.5× 151 0.9× 86 0.6× 114 1.1× 56 0.7× 45 777
Daniel Ng United States 17 287 0.9× 122 0.8× 55 0.4× 77 0.8× 131 1.6× 29 777
Stefan Zschiedrich Germany 13 248 0.8× 220 1.4× 68 0.5× 114 1.1× 40 0.5× 29 653
Makio Kawakami Japan 16 212 0.7× 112 0.7× 100 0.7× 216 2.2× 212 2.6× 48 784
Michael Sweeney United States 16 585 1.9× 63 0.4× 58 0.4× 142 1.4× 112 1.4× 35 884
Ewelina Kulikowski United States 19 771 2.5× 87 0.5× 76 0.5× 169 1.7× 159 2.0× 49 1.2k
Eng E United States 8 295 1.0× 253 1.6× 33 0.2× 110 1.1× 66 0.8× 12 701
Leonard A. Arbeit United States 13 88 0.3× 78 0.5× 126 0.8× 55 0.6× 63 0.8× 19 551
Claudia Izzi Italy 19 565 1.9× 311 1.9× 27 0.2× 206 2.1× 32 0.4× 52 1.3k
Wenhua Xiao China 18 500 1.6× 21 0.1× 231 1.5× 81 0.8× 218 2.7× 51 950

Countries citing papers authored by Bogusz Trojanowicz

Since Specialization
Citations

This map shows the geographic impact of Bogusz Trojanowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bogusz Trojanowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bogusz Trojanowicz more than expected).

Fields of papers citing papers by Bogusz Trojanowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bogusz Trojanowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bogusz Trojanowicz. The network helps show where Bogusz Trojanowicz may publish in the future.

Co-authorship network of co-authors of Bogusz Trojanowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Bogusz Trojanowicz. A scholar is included among the top collaborators of Bogusz Trojanowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bogusz Trojanowicz. Bogusz Trojanowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trojanowicz, Bogusz, Monika Haemmerle, Iréne Esposito, et al.. (2024). Gene expression dynamics in fibroblasts during early-stage murine pancreatic carcinogenesis. iScience. 28(1). 111572–111572. 3 indexed citations
2.
Trojanowicz, Bogusz, et al.. (2023). Influence of Ascorbic Acid as a Growth and Differentiation Factor on Dental Stem Cells Used in Regenerative Endodontic Therapies. Journal of Clinical Medicine. 12(3). 1196–1196. 4 indexed citations
3.
Sunami, Yoshiaki, et al.. (2022). Single Cell Analysis of Cultivated Fibroblasts from Chronic Pancreatitis and Pancreatic Cancer Patients. Cells. 11(16). 2583–2583. 4 indexed citations
4.
Ukkat, Jörg, Artur Rebelo, & Bogusz Trojanowicz. (2021). Angiogenetic transcriptional profiling reveals potential targets modulated in blood of patients with cardiovascular disorders. Vascular. 31(1). 152–162. 1 indexed citations
5.
Ulrich, Christof, Bogusz Trojanowicz, Roman Fiedler, et al.. (2021). Serum Testosterone Levels Are Not Modified by Vitamin D Supplementation in Dialysis Patients and Healthy Subjects. ˜The œNephron journals/Nephron journals. 145(5). 481–485. 5 indexed citations
6.
Ulrich, Christof, Roman Fiedler, Eric Seibert, et al.. (2021). Pyroptosis: A Common Feature of Immune Cells of Haemodialysis Patients. Toxins. 13(12). 839–839. 5 indexed citations
7.
Ukkat, Jörg, Cuong Hoang‐Vu, Bogusz Trojanowicz, & Artur Rebelo. (2021). Osteocalcin, Osteopontin and RUNX2 Expression in Patients’ Leucocytes with Arteriosclerosis. SHILAP Revista de lepidopterología. 9(1). 19–19. 8 indexed citations
8.
Trojanowicz, Bogusz, Christof Ulrich, & Matthias Girndt. (2020). Uremic Apelin and Leucocytic Angiotensin-Converting Enzyme 2 in CKD Patients. Toxins. 12(12). 742–742. 2 indexed citations
9.
Girndt, Matthias, Bogusz Trojanowicz, & Christof Ulrich. (2020). Monocytes in Uremia. Toxins. 12(5). 340–340. 28 indexed citations
10.
Ulrich, Christof, Roman Fiedler, Eric Seibert, et al.. (2020). NLRP3 Inflammasome Activation in Hemodialysis and Hypertensive Patients with Intact Kidney Function. Toxins. 12(11). 675–675. 16 indexed citations
11.
Narayan, Shoba, Kerstin Lorenz, Jörg Ukkat, Cuong Hoang‐Vu, & Bogusz Trojanowicz. (2019). Angiotensin converting enzymes ACE and ACE2 in thyroid cancer progression. Neoplasma. 67(2). 402–409. 22 indexed citations
12.
Trojanowicz, Bogusz, et al.. (2018). Circulating miR-421 Targeting Leucocytic Angiotensin Converting Enzyme 2 Is Elevated in Patients with Chronic Kidney Disease. ˜The œNephron journals/Nephron journals. 141(1). 61–74. 26 indexed citations
13.
Ulrich, Christof, et al.. (2016). Differential Expression of Lipoprotein-Associated Phospholipase A2 in Monocyte Subsets: Impact of Uremia and Atherosclerosis. ˜The œNephron journals/Nephron journals. 135(3). 231–241. 5 indexed citations
14.
Trojanowicz, Bogusz, et al.. (2016). Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease. Nephrology Dialysis Transplantation. 32(2). 287–298. 43 indexed citations
16.
Trojanowicz, Bogusz, Henning Dralle, & Cuong Hoang‐Vu. (2011). AUF1 and HuR: possible implications of mRNA stability in thyroid function and disorders. Thyroid Research. 4(S1). S5–S5. 13 indexed citations
17.
Trojanowicz, Bogusz, Ting Fu, Oliver Gimm, et al.. (2008). Relationship Between RKIP Protein Expression and Clinical Staging in Thyroid Carcinoma. 2(1). 16–20. 1 indexed citations
18.
Trojanowicz, Bogusz, Anja Winkler, Carsten Sekulla, et al.. (2008). Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines. Journal of Molecular Endocrinology. 42(3). 249–260. 33 indexed citations
19.
Hombach‐Klonisch, Sabine, Joanna Białek, Bogusz Trojanowicz, et al.. (2006). Relaxin Enhances the Oncogenic Potential of Human Thyroid Carcinoma Cells. American Journal Of Pathology. 169(2). 617–632. 62 indexed citations
20.
Mustafa, T., Bogusz Trojanowicz, Michael Brauckhoff, et al.. (2004). CD82, and CD63 in thyroid cancer.. PubMed. 14(4). 517–27. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026